Your Guide to Mounjaro Pens: Exactly How Many Doses Are In One?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro pens are pre-filled injection devices containing a 30-day supply of tirzepatide, a dual GLP-1 and GIP receptor agonist approved by the FDA in 2022 for type 2 diabetes and chronic weight management. Understanding how many doses come in each pen and how dosing schedules work helps you plan your treatment timeline and budget. PlexusDx compounded tirzepatide injections offer a personalized, transparent alternative with predictable monthly pricing.

How Many Injections Come in One Mounjaro Pen?

Each Mounjaro pen holds exactly four individual subcutaneous injections at a fixed dose concentration. Once you open a pen, you administer one injection per week for four weeks, then you need a new pen. This 28-day cycle means most people order a new supply monthly, though the exact timing depends on your prescribing schedule and refill protocol with your pharmacy.

The four doses in a single pen are all identical in strength—they do not escalate. If your doctor increases your dose tier, you receive a new pen with a higher concentration per injection. This design simplifies the user experience but creates a fixed-supply model that some patients find limiting if they need to pause, adjust, or taper their treatment.

Tirzepatide Dosing Tiers and Escalation Schedules

Tirzepatide dosing typically starts at 2.5 mg and escalates weekly by 2.5 mg increments: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg as a standard maintenance dose. Most patients spend one week at each tier before advancing, though your prescriber may adjust this timeline based on side-effect tolerance and clinical response. The escalation phase usually takes 4–8 weeks to reach your target dose.

Once you reach your maintenance dose, you continue that strength weekly for as long as treatment continues. Mounjaro pens lock you into whichever dose tier the pen contains; you cannot adjust mid-treatment without opening a new pen. PlexusDx compounded tirzepatide injections offer the same tiered dosing but with more flexibility, allowing micro-adjustments and personalized protocols based on your genetic predispositions and weight loss trajectory.

Compounded Tirzepatide vs. Mounjaro: Dosing and Supply Differences

PlexusDx tirzepatide injections are compounded by licensed 503A pharmacies and contain the same active ingredient as Mounjaro but arrive in multi-dose vials or personalized delivery formats. Rather than four fixed injections per pen, compounded tirzepatide allows your prescriber to prepare exactly the doses and volumes you need, supporting custom escalation protocols and dose adjustments without waste. This flexibility is especially valuable if you experience side effects at a standard tier or need to pause and restart therapy.

Pricing is transparent and predictable: PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat, regardless of dose tier. Your dose may need to go up. Your price won't. No insurance is required, and the medication is HSA/FSA eligible, making it accessible for patients seeking personalized, affordable weight loss therapy without brand-name pen markup or pharmacy insurance networks.

Genetic Testing and Personalized Tirzepatide Selection

Not every patient responds equally to tirzepatide. Genetic variants in the GLP1R, GIPR, FTO, and MC4R pathways influence how your body processes the medication and responds to weight loss signals. PlexusDx Precision Peptide Genetic Test analyzes 49 peptides across 14 biological pathways and 150+ genetic insights to reveal whether tirzepatide, semaglutide, or a dual-compound protocol is most likely to work for your unique genetic profile.

After your first month on any PlexusDx product, you can add the Precision Peptide Genetic Test for $99. The results inform your prescriber whether to continue your current compound, switch to an alternative GLP-1 option, or try PlexusDx GLP-Squared (a dual semaglutide-and-tirzepatide injection) for synergistic receptor activation. This data-driven approach eliminates trial-and-error dosing and helps you achieve faster, more sustainable results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does a Mounjaro pen have multiple dose strengths inside it?

No. A Mounjaro pen contains four identical injections at a single dose concentration. All four injections deliver the same milligram amount; there is no escalation within the pen. When you increase your dose, your prescriber provides a new pen with a higher concentration.

How often do I need to refill my Mounjaro pen prescription?

Most patients refill monthly because one pen supplies four weekly injections, lasting 28 days. The exact refill timing depends on your prescriber's dosing schedule and whether you are in an escalation phase or on a maintenance dose. PlexusDx compounded tirzepatide also uses a monthly billing cycle but may offer longer supplies depending on your prescription format.

Can I adjust my tirzepatide dose mid-month without opening a new pen?

With Mounjaro pens, no—you cannot adjust the dose mid-cycle because the pen contains four fixed, identical injections. With PlexusDx compounded tirzepatide, your prescriber has more flexibility to adjust your dose, taper gradually, or switch protocols based on your response and side effects, all while maintaining a flat $249/month price.

What if I want to pause or taper tirzepatide therapy?

Mounjaro pens are pre-filled for a full month, so pausing or tapering mid-cycle results in unused doses. PlexusDx compounded tirzepatide allows your prescriber to prepare customized tapering schedules and pause protocols without waste, giving you more control over your treatment timeline and reducing cost burden if you need to step back temporarily.

How does the PlexusDx Precision Peptide Genetic Test help me choose between tirzepatide and other GLP-1s?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro Doses
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.